Description
Added on the 06/01/2021 13:00:00 - Copyright : EFE Inglés
Laupheim (Germany), Feb 4 (EFE / EPA), (Camera: Ronald Wittek).- The biopharmaceutical company Rentschler Biopharma is working on the production of CureVac's first generation Covid-19 vaccine CVnCoV, which is currently in phase II and III of the clinical trial. FOOTAGE OF RENTSCHLER BIOPHARMA HEADQUARTERS IN LAUPHEIM, GERMANY.
Mainz (Germany), Jan 7 (EFE / EPA) .- (Camera: Ronald Wittek) Germany once again exceeded 1,000 coronavirus deaths in 24 hours for the second consecutive day, while new infections amounted to 26,391, according to data from the Robert Koch Institute(RKI) of Virology.FOOTAGE OF VACCINATION.
Idar-Oberstein (Germany), Dec 16 (EFE / EPA) .- (Camera: Ronald Wittek) The company BioNTech, based in the German city of Mainz, is developing together with the American company Pfizer its coronavirus vaccine at its facilities in Idar-Oberstein.FOOTAGE OF BIONTECH IDAR-OBERSTEIN.
Nordfriesland (Germany), Dec 3 (EFE / EPA), (Camera: Focke Strangmann).- Germany began the first test of a vaccination centre in the town of Nordfriesland, near the Danish border, on Thursday ahead of the arrival of the coronavirus vaccine.FOOTAGE OF THE COVID-19 VACCINATION CENTRE IN NORDFRIESLAND, GERMANY.
Mainz (Germany), 10 Nov (EFE/EPA) - (Camera: Ronald Wittek) The American pharmaceutical company Pfizer and the German company BioNTech announced Monday that their experimental vaccine against covid-19 shows an effectiveness of more than 90% in the participants without previous evidence of infection, more than required by the US regulators and even than expected by their directors.FOOTAGE OF BIONTECH'S HEADQUARTERS IN MAINZ, GERMANY
|
Support : Technical 
- Content 
- Editors 
